Bing Feng

1.7k total citations · 1 hit paper
35 papers, 1.3k citations indexed

About

Bing Feng is a scholar working on Cancer Research, Hepatology and Genetics. According to data from OpenAlex, Bing Feng has authored 35 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Cancer Research, 13 papers in Hepatology and 11 papers in Genetics. Recurrent topics in Bing Feng's work include Mesenchymal stem cell research (11 papers), Hepatocellular Carcinoma Treatment and Prognosis (10 papers) and MicroRNA in disease regulation (7 papers). Bing Feng is often cited by papers focused on Mesenchymal stem cell research (11 papers), Hepatocellular Carcinoma Treatment and Prognosis (10 papers) and MicroRNA in disease regulation (7 papers). Bing Feng collaborates with scholars based in China and United States. Bing Feng's co-authors include Longbang Chen, Hongcui Cao, Qiaoling Pan, Jiaqi Zhu, Lanjuan Li, Jiong Yu, Xudong Feng, Jiahang Zhou, Xiaowei Shi and Rui Wang and has published in prestigious journals such as Hepatology, Cellular and Molecular Life Sciences and Acta Biomaterialia.

In The Last Decade

Bing Feng

32 papers receiving 1.3k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Mesenchymal stem cells protect against ferroptosis via exosome-mediated stabilization of SLC7A11 in acute liver injury

2022 147 citations Feiyan Lin, Wenyi Chen et al. Cell Death and Disease profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Bing Feng China	23	670	523	283	254	201	35	1.3k
Jiliang Shen China	13	644 1.0×	353 0.7×	149 0.5×	201 0.8×	88 0.4×	29	1.1k
Giovanni Abbadessa United States	24	732 1.1×	170 0.3×	396 1.4×	235 0.9×	59 0.3×	99	1.7k
Junhui Sun China	17	218 0.3×	140 0.3×	567 2.0×	196 0.8×	113 0.6×	68	1.1k
Jianming Zheng China	22	912 1.4×	664 1.3×	73 0.3×	249 1.0×	138 0.7×	59	1.7k
Ioannis Diamantis Switzerland	20	374 0.6×	147 0.3×	255 0.9×	154 0.6×	67 0.3×	48	1.2k
Orlando Musso France	23	812 1.2×	478 0.9×	403 1.4×	151 0.6×	28 0.1×	40	1.6k
Bohao Zheng China	19	422 0.6×	333 0.6×	171 0.6×	241 0.9×	135 0.7×	53	1.3k
Nan You China	19	656 1.0×	410 0.8×	212 0.7×	139 0.5×	21 0.1×	61	1.3k
Ye Lin China	21	790 1.2×	674 1.3×	152 0.5×	235 0.9×	59 0.3×	59	1.5k
Kornélia Baghy Hungary	22	645 1.0×	277 0.5×	220 0.8×	111 0.4×	24 0.1×	54	1.3k

Countries citing papers authored by Bing Feng

Since Specialization

Citations

This map shows the geographic impact of Bing Feng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bing Feng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bing Feng more than expected).

Fields of papers citing papers by Bing Feng

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bing Feng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bing Feng. The network helps show where Bing Feng may publish in the future.

Co-authorship network of co-authors of Bing Feng

This figure shows the co-authorship network connecting the top 25 collaborators of Bing Feng. A scholar is included among the top collaborators of Bing Feng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bing Feng. Bing Feng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Wang, Ruo, Bing Feng, Qigu Yao, et al.. (2025). Human placenta mesenchymal stromal cells alleviate intestinal inflammation and repair intestinal barrier function by activating AMPK-FXR pathway. Communications Biology. 8(1). 830–830. 1 indexed citations

Feng, Xudong, Bing Feng, Jiahang Zhou, et al.. (2024). Mesenchymal stem cells alleviate mouse liver fibrosis by inhibiting pathogenic function of intrahepatic B cells. Hepatology. 81(4). 1211–1227. 32 indexed citations

Feng, Bing, Meng Liang, Dengfeng Li, et al.. (2024). Prognostic performance of MRI LI-RADS version 2018 features and clinical-pathological factors in alpha-fetoprotein-negative hepatocellular carcinoma. Abdominal Radiology. 49(6). 1918–1928.

Zhu, Jiaqi, Jiahang Zhou, Bing Feng, et al.. (2024). MSCs alleviate LPS-induced acute lung injury by inhibiting the proinflammatory function of macrophages in mouse lung organoid–macrophage model. Cellular and Molecular Life Sciences. 81(1). 124–124. 23 indexed citations

Zhu, Yongjian, Bing Feng, Bingzhi Wang, et al.. (2024). Bi-regional dynamic contrast-enhanced MRI for prediction of microvascular invasion in solitary BCLC stage A hepatocellular carcinoma. Insights into Imaging. 15(1). 149–149.

Feng, Bing, Dengfeng Li, Meng Liang, et al.. (2023). Risk stratification of solitary hepatocellular carcinoma ≤ 5 cm without microvascular invasion: prognostic values of MR imaging features based on LI-RADS and clinical parameters. European Radiology. 33(5). 3592–3603. 12 indexed citations

Feng, Bing, Xudong Feng, Qingqing Ye, et al.. (2023). Mesenchymal stem cells shift the pro-inflammatory phenotype of neutrophils to ameliorate acute lung injury. Stem Cell Research & Therapy. 14(1). 197–197. 22 indexed citations

Cong, Rong, Zhaowei Chen, Dengfeng Li, et al.. (2023). Determination of prognostic predictors in patients with solitary hepatocellular carcinoma: histogram analysis of multiparametric MRI. Abdominal Radiology. 48(11). 3362–3372. 1 indexed citations

Lin, Feiyan, Wenyi Chen, Jiahang Zhou, et al.. (2022). Mesenchymal stem cells protect against ferroptosis via exosome-mediated stabilization of SLC7A11 in acute liver injury. Cell Death and Disease. 13(3). 271–271. 147 indexed citations breakdown →

10.

Muhammad, Wali, Jiaqi Zhu, Zihe Zhai, et al.. (2022). ROS-responsive polymer nanoparticles with enhanced loading of dexamethasone effectively modulate the lung injury microenvironment. Acta Biomaterialia. 148. 258–270. 78 indexed citations

11.

Chen, Wenyi, Jiaqi Zhu, Feiyan Lin, et al.. (2021). Human placenta mesenchymal stem cell-derived exosomes delay H2O2-induced aging in mouse cholangioids. Stem Cell Research & Therapy. 12(1). 201–201. 26 indexed citations

12.

Feng, Xudong, Jiaqi Zhu, Jiahang Zhou, et al.. (2021). Hypoxia-inducible factor-1α–mediated upregulation of CD99 promotes the proliferation of placental mesenchymal stem cells by regulating ERK1/2. World Journal of Stem Cells. 13(4). 317–330. 10 indexed citations

13.

Zhu, Jiaqi, Bing Feng, Yanping Xu, et al.. (2020). Mesenchymal stem cells alleviate LPS-induced acute lung injury by inhibiting the proinflammatory function of Ly6C+ CD8+ T cells. Cell Death and Disease. 11(10). 829–829. 45 indexed citations

14.

Feng, Bing, Jiaqi Zhu, Yanping Xu, et al.. (2020). Immunosuppressive effects of mesenchymal stem cells on lung B cell gene expression in LPS-induced acute lung injury. Stem Cell Research & Therapy. 11(1). 418–418. 27 indexed citations

15.

Feng, Bing, Ying Zhu, Chao‐Yue Sun, et al.. (2019). Basil polysaccharide inhibits hypoxia-induced hepatocellular carcinoma metastasis and progression through suppression of HIF-1α-mediated epithelial-mesenchymal transition. International Journal of Biological Macromolecules. 137. 32–44. 29 indexed citations

16.

Liu, Jingqi, Bing Feng, Yanping Xu, et al.. (2019). Immunomodulatory effect of mesenchymal stem cells in chemical-induced liver injury: a high-dimensional analysis. Stem Cell Research & Therapy. 10(1). 262–262. 30 indexed citations

17.

Wang, Ting, Hao Zhou, Bing Feng, et al.. (2018). A Novel Aurora-A Inhibitor (MLN8237) Synergistically Enhances the Antitumor Activity of Sorafenib in Hepatocellular Carcinoma. Molecular Therapy — Nucleic Acids. 13. 176–188. 26 indexed citations

18.

Zhang, Bei, Siqi Han, Bing Feng, et al.. (2017). Hepatitis B virus X protein-mediated non-coding RNA aberrations in the development of human hepatocellular carcinoma. Experimental & Molecular Medicine. 49(2). e293–e293. 43 indexed citations

19.

Gao, Yanping, Jun Yi, Kai Zhang, et al.. (2017). Downregulation of MiR-31 stimulates expression of LATS2 via the hippo pathway and promotes epithelial-mesenchymal transition in esophageal squamous cell carcinoma. Journal of Experimental & Clinical Cancer Research. 36(1). 161–161. 50 indexed citations

20.

Yi, Jun, Jin Li, Jing Chen, et al.. (2016). MiR-375 suppresses invasion and metastasis by direct targeting of SHOX2 in esophageal squamous cell carcinoma. Acta Biochimica et Biophysica Sinica. 49(2). 159–169. 33 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact